NeuroPsyCAD
Braga
About NeuroPsyCAD
NeuroPsyCAD provides clinicians with patient-personalized reports for early and accurate diagnoses of neuropsychiatric disorders. NeuroPsyCAD's analysis pipeline is automated, with a report being produced in a few hours since they receive the patient's data. Given the high sensitivity and specificity of our approach, subtle changes in brain structure and function can be detected early and accurately at the disease onset, enabling clinicians to diagnose and, thus, treat patients earlier and with more confidence. NeuroPsyCAD aims to replace the so far relatively subjective and metrics-independent practice of psychiatry and neurology with a more quantified, objective, accurate, and personalize one.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $59.5K
- Funding stage: Seed
- Last round: Seed (Jan 2019)
- Website: neuropsycad.com
- Phone: [email protected]
Industries & Categories
Analytics, Health Care, Hospital, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neuropsycad-158274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.